Lord, Abbett & Co’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$5.2M Buy
2021
Q1
Sell
2020
Q4
$47.1M Buy
2020
Q3
$24.5M Buy
2020
Q2
$20.2M Sell
2020
Q1
$12.4M Buy
2019
Q4
$17.2M Sell
2019
Q3
$14.6M Buy
2018
Q3
Sell
2018
Q2
$13.3M Buy
2017
Q1
Sell
2016
Q4
$4.29M Buy